Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis

Authors: Kuan-Chin Wang, Wen-Hsun Chang, Wen-Ling Lee, Nicole Huang, Hsin-Yi Huang, Ming-Shyen Yen, Chao-Yu Guo, Peng-Hui Wang

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

Epidemiological evidence of relationships between endometriosis and epithelial ovarian cancer (EOC) has been obtained mainly from Western countries. Our goal was to determine the risk of EOC due to endometriosis in Taiwanese women.

Methods

A retrospective cohort study was performed by linking to the National Health Insurance Research Database (NHIRD) of Taiwan. A total of 5,945 women with a new surgico-pathological diagnosis of endometriosis from 2000 to 2010 and 23,780 multivariable-matched controls (1:4) were selected. The Cox regression model adjusted for potential confounders was used to assess the risk of EOC due to endometriosis.

Results

The EOC incidence rate (IR) of the women with and without endometriosis was 11.64 and 2.66 per 10,000 person-years, contributing to a crude hazard ratio (HR) of 4.48 (95% confidence interval [CI] 2.84-7.06), and HR after adjustment for all confounders (adjusted HR) of 5.62 (95% CI 3.46-9.14); the risk was higher in clear-cell carcinoma subtypes (adjusted HR 7.36, 95% CI 1.91-28.33). The EOC IR of women with endometriosis consistently increased with increasing age, ranging from 4.99 (<30 years) to 35.81 (≥50 years) per 10,000 person-years, contributing to a progressively increased risk of EOC (crude HRs ranging from 2.80 to 6.74 and adjusted HRs ranging from 3.34 to 9.63) compared to age-matched women without endometriosis, whose EOC IR also increased with age. The older women (≥50 years) with endometriosis had a risk of EOC that was higher than both the age-matched women without endometriosis (adjusted HR 9.63, 95% CI 3.27-28.37) and the youngest women (<30 years) with endometriosis (adjusted HR 4.97, 95% CI 1.03-24.09).

Conclusions

These significant findings corroborate the previously reported association between endometriosis and increased risk of EOC. Since the risk of EOC in women with a new surgico-pathological diagnosis of endometriosis constantly increased with age and this increased risk of EOC was more significant in women aged ≥50 years, active and intensive surgical intervention should be taken into consideration for older women with endometriosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kobayashi H, Sumimoto K, Kitanaka T, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R, Kanayama S, Shigetomi H, Haruta S, Tsuji Y, Ueda S, Terao T: Ovarian endometrioma–risks factors of ovarian cancer development. Eur J Obstet Gynecol Reprod Biol. 2008, 138: 187-93. 10.1016/j.ejogrb.2007.06.017.CrossRefPubMed Kobayashi H, Sumimoto K, Kitanaka T, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R, Kanayama S, Shigetomi H, Haruta S, Tsuji Y, Ueda S, Terao T: Ovarian endometrioma–risks factors of ovarian cancer development. Eur J Obstet Gynecol Reprod Biol. 2008, 138: 187-93. 10.1016/j.ejogrb.2007.06.017.CrossRefPubMed
2.
go back to reference Aris A: Endometriosis-associated ovarian cancer: a ten-year cohort study of women living in the Estrie Region of Quebec, Canada. J Ovarian Res. 2010, 3: 2-10.1186/1757-2215-3-2.CrossRefPubMedPubMedCentral Aris A: Endometriosis-associated ovarian cancer: a ten-year cohort study of women living in the Estrie Region of Quebec, Canada. J Ovarian Res. 2010, 3: 2-10.1186/1757-2215-3-2.CrossRefPubMedPubMedCentral
3.
go back to reference Borgfeldt C, Andolf E: Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand. 2004, 83: 395-400. 10.1080/j.0001-6349.2004.00305.x.CrossRefPubMed Borgfeldt C, Andolf E: Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand. 2004, 83: 395-400. 10.1080/j.0001-6349.2004.00305.x.CrossRefPubMed
4.
go back to reference Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A: Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol. 1997, 176: 572-579. 10.1016/S0002-9378(97)70550-7.CrossRefPubMed Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A: Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol. 1997, 176: 572-579. 10.1016/S0002-9378(97)70550-7.CrossRefPubMed
5.
go back to reference Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL: Ovarian cancer risk associated with varying causes of infertility. Fertil Steril. 2004, 82: 405-414. 10.1016/j.fertnstert.2004.02.109.CrossRefPubMed Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE, Westhoff CL: Ovarian cancer risk associated with varying causes of infertility. Fertil Steril. 2004, 82: 405-414. 10.1016/j.fertnstert.2004.02.109.CrossRefPubMed
6.
go back to reference Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Trabert B, Niwa S, Moghissi KS: Causes of infertility as predictors of subsequent cancer risk. Epidemiology. 2005, 16: 500-507. 10.1097/01.ede.0000164812.02181.d5.CrossRefPubMed Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Trabert B, Niwa S, Moghissi KS: Causes of infertility as predictors of subsequent cancer risk. Epidemiology. 2005, 16: 500-507. 10.1097/01.ede.0000164812.02181.d5.CrossRefPubMed
7.
go back to reference Brinton LA, Sakoda LC, Sherman ME, Frederiksen K, Kjaer SK, Graubard BI, Olsen JH, Mellemkjaer L: Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2929-2935. 10.1158/1055-9965.EPI-05-0394.CrossRefPubMed Brinton LA, Sakoda LC, Sherman ME, Frederiksen K, Kjaer SK, Graubard BI, Olsen JH, Mellemkjaer L: Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiol Biomarkers Prev. 2005, 14: 2929-2935. 10.1158/1055-9965.EPI-05-0394.CrossRefPubMed
8.
go back to reference Kotsopoulos J, Terry KL, Poole EM, Rosner B, Murphy MA, Hecht JL, Crum CP, Missmer SA, Cramer DW, Tworoger SS: Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin. Int J Cancer. 2013, 133: 730-739. 10.1002/ijc.28064.CrossRefPubMedPubMedCentral Kotsopoulos J, Terry KL, Poole EM, Rosner B, Murphy MA, Hecht JL, Crum CP, Missmer SA, Cramer DW, Tworoger SS: Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin. Int J Cancer. 2013, 133: 730-739. 10.1002/ijc.28064.CrossRefPubMedPubMedCentral
9.
go back to reference Melin A, Sparen P, Persson I, Bergqvist A: Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod. 2006, 21: 1237-1242. 10.1093/humrep/dei462.CrossRefPubMed Melin A, Sparen P, Persson I, Bergqvist A: Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod. 2006, 21: 1237-1242. 10.1093/humrep/dei462.CrossRefPubMed
10.
go back to reference Melin A, Sparén P, Bergqvist A: The risk of cancer and the role of parity among women with endometriosis. Hum Reprod. 2007, 22: 3021-3026. 10.1093/humrep/dem209.CrossRefPubMed Melin A, Sparén P, Bergqvist A: The risk of cancer and the role of parity among women with endometriosis. Hum Reprod. 2007, 22: 3021-3026. 10.1093/humrep/dem209.CrossRefPubMed
11.
go back to reference Melin AS, Lundholm C, Malki N, Swahn ML, Sparèn P, Bergqvist A: Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer. Acta Obstet Gynecol Scand. 2013, 92: 546-554. 10.1111/aogs.12123.CrossRefPubMed Melin AS, Lundholm C, Malki N, Swahn ML, Sparèn P, Bergqvist A: Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer. Acta Obstet Gynecol Scand. 2013, 92: 546-554. 10.1111/aogs.12123.CrossRefPubMed
12.
go back to reference Merritt MA, Green AC, Nagle CM, Webb PM, Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group: Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer. 2008, 122: 170-176. 10.1002/ijc.23017.CrossRefPubMed Merritt MA, Green AC, Nagle CM, Webb PM, Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group: Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer. 2008, 122: 170-176. 10.1002/ijc.23017.CrossRefPubMed
13.
go back to reference Merritt MA, De Pari M, Vitonis AF, Titus LJ, Cramer DW, Terry KL: Reproductive characteristics in relation to ovarian cancer risk by histologic pathways. Hum Reprod. 2013, 28: 1406-1417. 10.1093/humrep/des466.CrossRefPubMedPubMedCentral Merritt MA, De Pari M, Vitonis AF, Titus LJ, Cramer DW, Terry KL: Reproductive characteristics in relation to ovarian cancer risk by histologic pathways. Hum Reprod. 2013, 28: 1406-1417. 10.1093/humrep/des466.CrossRefPubMedPubMedCentral
14.
go back to reference Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT: Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol. 2004, 191: 733-740. 10.1016/j.ajog.2004.03.035.CrossRefPubMed Modugno F, Ness RB, Allen GO, Schildkraut JM, Davis FG, Goodman MT: Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol. 2004, 191: 733-740. 10.1016/j.ajog.2004.03.035.CrossRefPubMed
15.
go back to reference Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA: Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women’s Health Study. Cancer. 2002, 94: 1612-1618. 10.1002/cncr.10370.CrossRefPubMed Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA: Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women’s Health Study. Cancer. 2002, 94: 1612-1618. 10.1002/cncr.10370.CrossRefPubMed
16.
go back to reference Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, Goodman MT, Moysich K, Kjaer SK, Hogdall E, Jensen A, Goode EL, Fridley BL, Larson MC, Schildkraut JM, Palmieri RT, Cramer DW, Terry KL, Vitonis AF, Titus LJ, Ziogas A, et al: Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies. Lancet Oncol. 2012, 13: 385-394. 10.1016/S1470-2045(11)70404-1.CrossRefPubMedPubMedCentral Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, Goodman MT, Moysich K, Kjaer SK, Hogdall E, Jensen A, Goode EL, Fridley BL, Larson MC, Schildkraut JM, Palmieri RT, Cramer DW, Terry KL, Vitonis AF, Titus LJ, Ziogas A, et al: Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies. Lancet Oncol. 2012, 13: 385-394. 10.1016/S1470-2045(11)70404-1.CrossRefPubMedPubMedCentral
17.
go back to reference Pearce CL, Rossing MA, Lee AW, Ness RB, Webb PM, Chenevix-Trench G, Jordan SM, Stram DA, Chang-Claude J, Hein R, Nickels S, Lurie G, Thompson PJ, Carney ME, Goodman MT, Moysich K, Hogdall E, Jensen A, Goode EL, Fridley BL, Cunningham JM, Vierkant RA, Weber RP, Ziogas A, Anton-Culver H, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, et al: Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2013, 22: 880-890. 10.1158/1055-9965.EPI-12-1030-T.CrossRefPubMedPubMedCentral Pearce CL, Rossing MA, Lee AW, Ness RB, Webb PM, Chenevix-Trench G, Jordan SM, Stram DA, Chang-Claude J, Hein R, Nickels S, Lurie G, Thompson PJ, Carney ME, Goodman MT, Moysich K, Hogdall E, Jensen A, Goode EL, Fridley BL, Cunningham JM, Vierkant RA, Weber RP, Ziogas A, Anton-Culver H, Gayther SA, Gentry-Maharaj A, Menon U, Ramus SJ, Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, et al: Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2013, 22: 880-890. 10.1158/1055-9965.EPI-12-1030-T.CrossRefPubMedPubMedCentral
18.
go back to reference Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG: Ovarian tumors in a cohort of infertile women. N Engl J Med. 1994, 331: 771-776. 10.1056/NEJM199409223311204.CrossRefPubMed Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG: Ovarian tumors in a cohort of infertile women. N Engl J Med. 1994, 331: 771-776. 10.1056/NEJM199409223311204.CrossRefPubMed
19.
go back to reference Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS: Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes Control. 2008, 19: 1357-1364. 10.1007/s10552-008-9207-9.CrossRefPubMedPubMedCentral Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS: Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes Control. 2008, 19: 1357-1364. 10.1007/s10552-008-9207-9.CrossRefPubMedPubMedCentral
20.
go back to reference Stewart LM, Holman CD, Aboagye-Sarfo P, Finn JC, Preen DB, Hart R: In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk. Gynecol Oncol. 2013, 128: 260-264. 10.1016/j.ygyno.2012.10.023.CrossRefPubMed Stewart LM, Holman CD, Aboagye-Sarfo P, Finn JC, Preen DB, Hart R: In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk. Gynecol Oncol. 2013, 128: 260-264. 10.1016/j.ygyno.2012.10.023.CrossRefPubMed
21.
go back to reference Venn A, Watson L, Lumley J, Giles G, King C, Healy D: Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet. 1995, 346: 995-1000. 10.1016/S0140-6736(95)91687-3.CrossRefPubMed Venn A, Watson L, Lumley J, Giles G, King C, Healy D: Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet. 1995, 346: 995-1000. 10.1016/S0140-6736(95)91687-3.CrossRefPubMed
22.
go back to reference Buis CC, Van Leeuwen FE, Mooij TM, Burger CW, OMEGA Project Group: Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis. Hum Reprod. 2013, 28: 3358-3369. 10.1093/humrep/det340.CrossRefPubMed Buis CC, Van Leeuwen FE, Mooij TM, Burger CW, OMEGA Project Group: Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis. Hum Reprod. 2013, 28: 3358-3369. 10.1093/humrep/det340.CrossRefPubMed
23.
go back to reference Heidemann LN, Hartwell D, Heidemann CH, Jochumsen KM: The relation between endometriosis and ovarian cancer - a review. Acta Obstet Gynecol Scand. 2014, 93: 20-31. 10.1111/aogs.12255.CrossRefPubMed Heidemann LN, Hartwell D, Heidemann CH, Jochumsen KM: The relation between endometriosis and ovarian cancer - a review. Acta Obstet Gynecol Scand. 2014, 93: 20-31. 10.1111/aogs.12255.CrossRefPubMed
24.
go back to reference Scarfone G, Bergamini A, Noli S, Villa A, Cipriani S, Taccagni G, Vigano' P, Candiani M, Parazzini F, Mangili G: Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study. Gynecol Oncol. 2014, 133: 480-484. 10.1016/j.ygyno.2014.03.017.CrossRefPubMed Scarfone G, Bergamini A, Noli S, Villa A, Cipriani S, Taccagni G, Vigano' P, Candiani M, Parazzini F, Mangili G: Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study. Gynecol Oncol. 2014, 133: 480-484. 10.1016/j.ygyno.2014.03.017.CrossRefPubMed
25.
go back to reference Kim HS, Kim TH, Chung HH, Song YS: Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis. Br J Cancer. 2014, 110: 1878-1890. 10.1038/bjc.2014.29.CrossRefPubMedPubMedCentral Kim HS, Kim TH, Chung HH, Song YS: Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis. Br J Cancer. 2014, 110: 1878-1890. 10.1038/bjc.2014.29.CrossRefPubMedPubMedCentral
26.
go back to reference Rothwell PM: Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet. 2005, 365: 176-186. 10.1016/S0140-6736(05)17709-5.CrossRefPubMed Rothwell PM: Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet. 2005, 365: 176-186. 10.1016/S0140-6736(05)17709-5.CrossRefPubMed
27.
go back to reference Papathanasiou A: Implementing the ESHRE 'poor responder' criteria in research studies: methodological implications. Hum Reprod. 2014, 29: 1835-1838. 10.1093/humrep/deu135.CrossRefPubMed Papathanasiou A: Implementing the ESHRE 'poor responder' criteria in research studies: methodological implications. Hum Reprod. 2014, 29: 1835-1838. 10.1093/humrep/deu135.CrossRefPubMed
28.
go back to reference Wang PH, Chang YH, Yang YH, Chang WH, Huang SY, Lai CR, Juang CM, Chen YJ, Horng HC, Wen KC, Ng HT, Yuan CC, Chao KC, Yen MS: Outcome of patients with bulky IB (≥6 cm) cervical squamous cell carcinoma with and without cisplatin-based neoadjuvant chemotherapy. Taiwan J Obstet Gynecol. 2014, 53: 330-336. 10.1016/j.tjog.2014.05.001.CrossRefPubMed Wang PH, Chang YH, Yang YH, Chang WH, Huang SY, Lai CR, Juang CM, Chen YJ, Horng HC, Wen KC, Ng HT, Yuan CC, Chao KC, Yen MS: Outcome of patients with bulky IB (≥6 cm) cervical squamous cell carcinoma with and without cisplatin-based neoadjuvant chemotherapy. Taiwan J Obstet Gynecol. 2014, 53: 330-336. 10.1016/j.tjog.2014.05.001.CrossRefPubMed
29.
go back to reference Yang MH, Wang PH, Wang SJ, Sun WZ, Oyang YJ, Fuh JL: Women with endometriosis are more likely to suffer from migraines: a population-based study. PLoS One. 2012, 7: e33941-10.1371/journal.pone.0033941.CrossRefPubMedPubMedCentral Yang MH, Wang PH, Wang SJ, Sun WZ, Oyang YJ, Fuh JL: Women with endometriosis are more likely to suffer from migraines: a population-based study. PLoS One. 2012, 7: e33941-10.1371/journal.pone.0033941.CrossRefPubMedPubMedCentral
30.
go back to reference Jou HJ, Siao RY, Tsai YS, Chen YT, Li CY, Chen CC: Postdischarge rehospitalization and in-hospital mortality among Taiwanese women with hip fracture. Taiwan J Obstet Gynecol. 2014, 53: 43-47. 10.1016/j.tjog.2012.04.042.CrossRefPubMed Jou HJ, Siao RY, Tsai YS, Chen YT, Li CY, Chen CC: Postdischarge rehospitalization and in-hospital mortality among Taiwanese women with hip fracture. Taiwan J Obstet Gynecol. 2014, 53: 43-47. 10.1016/j.tjog.2012.04.042.CrossRefPubMed
31.
go back to reference Chiang YC, Chen CA, Chiang CJ, Hsu TH, Lin MC, You SL, Cheng WF, Lai MS: Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan. J Gynecol Oncol. 2013, 24: 342-351. 10.3802/jgo.2013.24.4.342.CrossRefPubMedPubMedCentral Chiang YC, Chen CA, Chiang CJ, Hsu TH, Lin MC, You SL, Cheng WF, Lai MS: Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan. J Gynecol Oncol. 2013, 24: 342-351. 10.3802/jgo.2013.24.4.342.CrossRefPubMedPubMedCentral
32.
go back to reference Köbel M, Kalloger SE, Baker PM, Ewanowich CA, Arseneau J, Zherebitskiy V, Abdulkarim S, Leung S, Duggan MA, Fontaine D, Parker R, Huntsman DG, Gilks CB: Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study. Am J Surg Pathol. 2010, 34: 984-993. 10.1097/PAS.0b013e3181e1a3bb.CrossRefPubMed Köbel M, Kalloger SE, Baker PM, Ewanowich CA, Arseneau J, Zherebitskiy V, Abdulkarim S, Leung S, Duggan MA, Fontaine D, Parker R, Huntsman DG, Gilks CB: Diagnosis of ovarian carcinoma cell type is highly reproducible: a transcanadian study. Am J Surg Pathol. 2010, 34: 984-993. 10.1097/PAS.0b013e3181e1a3bb.CrossRefPubMed
33.
go back to reference Lin DY, Wei LJ: The robust inference for the proportional hazards model. J Am Stat Assoc. 1989, 84: 1074-1078. 10.1080/01621459.1989.10478874.CrossRef Lin DY, Wei LJ: The robust inference for the proportional hazards model. J Am Stat Assoc. 1989, 84: 1074-1078. 10.1080/01621459.1989.10478874.CrossRef
35.
go back to reference Nezhat FR, Pejovic T, Reis FM, Guo SW: The link between endometriosis and ovarian cancer: clinical implications. Int J Gynecol Cancer. 2014, 24: 623-628. 10.1097/IGC.0000000000000100.CrossRefPubMed Nezhat FR, Pejovic T, Reis FM, Guo SW: The link between endometriosis and ovarian cancer: clinical implications. Int J Gynecol Cancer. 2014, 24: 623-628. 10.1097/IGC.0000000000000100.CrossRefPubMed
36.
go back to reference Van Gorp T, Amant F, Neven P, Vergote I: Endometriosis and the development of malignant tumours of the pelvis. A review of literature. Best Pract Res Clin Obstet Gynaecol. 2004, 18: 349-371. 10.1016/j.bpobgyn.2003.03.001.CrossRefPubMed Van Gorp T, Amant F, Neven P, Vergote I: Endometriosis and the development of malignant tumours of the pelvis. A review of literature. Best Pract Res Clin Obstet Gynaecol. 2004, 18: 349-371. 10.1016/j.bpobgyn.2003.03.001.CrossRefPubMed
37.
go back to reference Tay SK, Cheong MA: Evidence for ethnic and environmental contributions to frequency of ovarian clear cell carcinoma. Aust N Z J Obstet Gynaecol. 2014, 54: 225-230. 10.1111/ajo.12188.CrossRefPubMed Tay SK, Cheong MA: Evidence for ethnic and environmental contributions to frequency of ovarian clear cell carcinoma. Aust N Z J Obstet Gynaecol. 2014, 54: 225-230. 10.1111/ajo.12188.CrossRefPubMed
38.
go back to reference Vercellini P, Somigliana E, Buggio L: Endometriosis and ovarian cancer. Lancet Oncol. 2012, 13: e188-e189.CrossRefPubMed Vercellini P, Somigliana E, Buggio L: Endometriosis and ovarian cancer. Lancet Oncol. 2012, 13: e188-e189.CrossRefPubMed
39.
go back to reference Rice MS, Murphy MA, Vitonis AF, Cramer DW, Titus LJ, Tworoger SS, Terry KL: Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England case–control study. Int J Cancer. 2013, 133: 2415-2421. 10.1002/ijc.28249.CrossRefPubMedPubMedCentral Rice MS, Murphy MA, Vitonis AF, Cramer DW, Titus LJ, Tworoger SS, Terry KL: Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England case–control study. Int J Cancer. 2013, 133: 2415-2421. 10.1002/ijc.28249.CrossRefPubMedPubMedCentral
40.
go back to reference Lai CR, Hsu CY, Chen YJ, Yen MS, Chao KC, Li AF: Ovarian cancers arising from endometriosis: a microenvironmental biomarker study including ER, HNF1ß, p53, PTEN, BAF250a, and COX-2. J Chin Med Assoc. 2013, 76: 629-634. 10.1016/j.jcma.2013.07.008.CrossRefPubMed Lai CR, Hsu CY, Chen YJ, Yen MS, Chao KC, Li AF: Ovarian cancers arising from endometriosis: a microenvironmental biomarker study including ER, HNF1ß, p53, PTEN, BAF250a, and COX-2. J Chin Med Assoc. 2013, 76: 629-634. 10.1016/j.jcma.2013.07.008.CrossRefPubMed
41.
go back to reference Horng HC, Chen CH, Chen CY, Tsui KH, Liu WM, Wang PH, Chang WH, Huang BS, Sun HD, Chang TC, Chang WC, Yen MS: Uterine-sparing surgery for adenomyosis and/or adenomyoma. Taiwan J Obstet Gynecol. 2014, 53: 3-7. 10.1016/j.tjog.2014.01.001.CrossRefPubMed Horng HC, Chen CH, Chen CY, Tsui KH, Liu WM, Wang PH, Chang WH, Huang BS, Sun HD, Chang TC, Chang WC, Yen MS: Uterine-sparing surgery for adenomyosis and/or adenomyoma. Taiwan J Obstet Gynecol. 2014, 53: 3-7. 10.1016/j.tjog.2014.01.001.CrossRefPubMed
Metadata
Title
An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis
Authors
Kuan-Chin Wang
Wen-Hsun Chang
Wen-Ling Lee
Nicole Huang
Hsin-Yi Huang
Ming-Shyen Yen
Chao-Yu Guo
Peng-Hui Wang
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-831

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine